BioEye
BioEye is a medical device company specializing in ophthalmic implants and related products.
Profile
Develops ophthalmic implants and related medical devices for eye care.
BioEye is a medical device company specializing in ophthalmic implants and related products. The company's Coated BioEye Orbital Implant with Conformer was subject to a Class 2 Device Recall by the FDA, indicating a moderate risk of adverse health consequences. The recall suggests potential quality control or manufacturing issues that could impact patient safety.
BioEye's focus on ocular health places it in a competitive market with increasing regulatory scrutiny, particularly following a series of eye drop and ointment recalls industry-wide from 2023 to 2026. The company's website, which appears to be under development or experiencing technical issues, does not provide clear information on its founding date, headquarters, or leadership team. This lack of transparency raises questions about its operational stability and governance. The recall of its orbital implant product underscores the challenges BioEye faces in maintaining compliance with FDA standards and ensuring product safety in a highly regulated sector.
Who buys this
- Ophthalmologists and eye surgeons
- Hospitals and surgical centers
- Medical device distributors
- Patients requiring ocular implants
Strengths and what to watch
Strengths
- Specialization in ophthalmic implants, a niche but critical medical market.
- Products designed to address specific ocular health needs, such as orbital implants.
- Operates in a sector with high barriers to entry due to regulatory requirements.
Watch for
- Recent FDA Class 2 recall of the Coated BioEye Orbital Implant with Conformer, indicating potential safety or quality issues.
- Lack of publicly available information on company leadership, funding, or operational status.
- Competitive pressure from larger medical device companies with more robust R&D and compliance capabilities.
Key Information
- Founded
- 2017
- Headquarters
- Sydney, New South Wales
Frequently Asked Questions
What does BioEye do?
BioEye develops ophthalmic implants and related medical devices for eye care. The company specializes in products like orbital implants, addressing specific ocular health needs. Their focus on this niche market places them in a competitive and highly regulated sector.
What is the BioEye orbital implant recall?
BioEye's Coated BioEye Orbital Implant with Conformer was subject to an FDA Class 2 recall, indicating a moderate risk of adverse health consequences. This suggests potential quality control or manufacturing issues, raising concerns about patient safety and regulatory compliance.
What are the risks of BioEye's orbital implant?
The FDA Class 2 recall of BioEye's orbital implant highlights potential safety risks, including adverse health consequences. The recall suggests issues in manufacturing or quality control, which could impact patient outcomes and the company's compliance with regulatory standards.
Is BioEye transparent about its operations?
BioEye lacks transparency regarding its leadership, funding, and operational status. The company's website provides limited information, raising questions about its governance and stability. This opacity contrasts with the need for clarity in the highly regulated medical device industry.
Who uses BioEye's products?
BioEye's products are used by ophthalmologists, eye surgeons, hospitals, surgical centers, and medical device distributors. Their ophthalmic implants cater to patients requiring ocular health solutions, positioning the company in a niche but critical medical market.
How does BioEye compare to competitors?
BioEye faces competitive pressure from larger medical device companies with stronger R&D and compliance capabilities. While specializing in ophthalmic implants, the recent FDA recall and lack of transparency pose challenges to its market position and regulatory standing.
Sources
- www.accessdata.fda.gov — FDA Class 2 recall of BioEye's orbital implant product.
- www.goodrx.com — Context on industry-wide recalls of ophthalmic products.
- www.bioeye.com — Company website, though limited in operational details.